Here is the recursion nobody enjoys. Your automated test tool produces the evidence that another system is validated. So what validates the tool?
Ignore it and an inspector will find it. Over-engineer it and you will spend more qualifying the tool than the tool ever saves. There is a proportionate middle, and it depends on what the tool is allowed to do.
Yes, it is in scope
The test is simple: does the tool's output influence a GxP decision? A tool whose results determine whether a system is released for GxP use plainly does. It is a computerised system supporting a regulated process, and GAMP 5 Second Edition consulting treats it accordingly.
What that does not mean is a full IQ/OQ/PQ of the test tool with the same rigour as the system under test. GAMP 5 Second Edition is explicit about scaling effort to risk, and the risk here is specific and bounded: that the tool reports a pass when the system actually failed, or records evidence that does not reflect what happened.
The risk is narrower than it looks
Once you write down the failure modes that actually matter, the qualification scope becomes obvious.
- False pass. The tool reports success when the assertion should have failed. This is the serious one — it is the only failure mode that lets a defective system through.
- Evidence that does not match the run. Screenshots from the wrong step, timestamps that are not contemporaneous, a result recorded against the wrong protocol version.
- Silent skipping. A step that did not execute being reported as passed, or an error being swallowed.
- Mutable records. Results that can be edited after the fact without an audit trail.
A false failure, by contrast, is a nuisance rather than a compliance risk — it costs an investigation and finds nothing. That asymmetry is what lets you scope the qualification tightly.
A proportionate qualification
For most teams, this is a matter of days rather than months:
- Supplier assessment of the vendor, or of your own development process if the tool is internal. See supplier qualification.
- Installation verification — the version you qualified is the version in use, and you can tell when it changes.
- A negative test set. The single most valuable artefact: a suite of deliberately failing tests that the tool must report as failures. This directly attacks the false-pass risk and is cheap to maintain.
- Evidence integrity checks — confirm that results cannot be altered after the run, and that the audit trail records who did what.
- Re-qualification on version change, scoped by what changed.
The negative test set is the part teams skip and the part an inspector will ask about. Everyone can show their tool passing. Showing that it correctly fails is the evidence that a pass means something.
Why a smaller vocabulary means a smaller qualification
This is where the design of the tool feeds back into the cost of owning it. A tool with a closed set of step types has a finite surface to qualify: you can enumerate every step type and demonstrate each one behaves correctly, including when it should fail.
A tool that can execute arbitrary code has no such boundary. You are not qualifying a list of behaviours, you are qualifying an interpreter — and the honest response is to move the controls into procedure and access management instead, which is a heavier ongoing burden even though it looks lighter at the start.
It is a reasonable thing to weigh at selection time rather than discovering after purchase.
Where to go next
Explore GxP Copilot for AI-native validation, TraceDraft for source-traceable clinical documentation, or book a demo to see either on your own data.